Empirical validation of a cerebellar-cortical hallucination circuit

小脑皮质幻觉回路的实证验证

基本信息

  • 批准号:
    10364077
  • 负责人:
  • 金额:
    $ 66.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-01 至 2026-10-31
  • 项目状态:
    未结题

项目摘要

Project Summary / Abstract Projects like the BRAIN initiative hold the potential for a fundamentally new approach to therapeutics for severe mental illness. Neuromodulation technologies promise to allow selective intervention in which pathophysiology is specifically targeted for correction. These initiatives are critically dependent on the correct identification of circuit dysfunction that causes psychiatric symptoms. NIMH has prioritized this as a strategic objective: Identify and characterize the neural circuit mechanisms contributing to human behavior and their disruption in mental illnesses. Neuroimaging studies have generated promising leads while almost never demonstrating that these findings represent targets that can be engaged for therapeutic benefit. We thus lack a key perquisite for translation into the clinic: For imaging biomarkers to make the leap to translational use, they would need to accurately identify the circuits that give rise to symptoms. In this project we seek to understand how brain circuit dysfunction causes auditory hallucinations in schizophrenia. Published, technically challenging imaging studies provide a critical clue: These “symptom capture” experiments that collect MRI imaging during hallucinations have identified a disparate pattern of activations across multiple subcortical and cortical brain regions. Our hypothesis is that these brain regions are part of a single circuit than spans cerebellar, thalamic, and cortical brain regions. In our preliminary data we are able to identify the cerebellar node of this circuit, and then, in an independent cohort of participants with schizophrenia, we used neuromodulation to manipulate this circuit. We observe that non-invasive neuromodulation can manipulate connectivity across this entire circuit. Restoration of connectivity in this circuit is reflected in reduction of hallucination severity. In this proposal we seek to confirm and extend this result. We will use non-invasive neuromodulation to specifically target this circuit and observe change induced on the hallucination circuit in a sham-controlled study. If successful, this project will establish a circuit-level understanding of how pathophysiology is causally linked to hallucinations. This kind of mechanistic understanding of schizophrenia symptoms would be unprecedented and would identify biological target for engagement to reduce these symptoms.
项目摘要 /摘要 诸如大脑启动之类的项目具有从根本上进行新的治疗方法 严重的精神疾病。神经调节技术有望允许选择性干预 病理生理学专门针对矫正。这些举措在关键上取决于正确的 导致精神病症状的电路功能障碍的识别。 NIMH将其视为一种策略 目的:确定并表征有助于人类行为及其其行为的神经回路机制 精神疾病的破坏。 神经影像学研究产生了诺言,而几乎从未证明这些 调查结果代表可以从事治疗益处的目标。因此,我们缺乏关键的建议 翻译成诊所:要想成像生物标志物,以使翻译使用跃升,他们需要 准确地确定引起症状的电路。 在这个项目中,我们试图了解脑电路功能障碍如何引起听觉幻觉 精神分裂症。发表的技术挑战成像研究提供了关键的线索:这些'症状 捕获”在幻觉期间收集MRI成像的实验已经确定了不同的模式 多个皮质下和皮质大脑区域的激活。我们的假设是这些大脑区域 是单个电路的一部分,而不是跨越小脑,丘脑和皮质脑区域。在我们的初步数据中 能够识别该电路的小脑节点,然后在独立的参与者中 精神分裂症,我们使用神经调节来操纵该电路。我们观察到无创的 神经调节可以在整个电路上操纵连通性。恢复该电路中的连通性 反映在降低幻觉的严重程度上。 在此提案中,我们寻求确认并扩展此结果。我们将使用非侵入性神经调节 特别针对该电路,并观察在幻觉电路上引起的变化 学习。如果成功,该项目将建立对病理生理如何因果生理学的理解 与幻觉有关。这种对精神分裂症症状的机械理解将是 前所未有的,将确定参与的生物学目标以减少这些符号。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Roscoe O. Brady其他文献

The Metabolism of Ceramide Trihexosides: I. PURIFICATION AND PROPERTIES OF AN ENZYME THAT CLEAVES THE TERMINAL GALACTOSE MOLECULE OF GALACTOSYLGALACTOSYLGLUCOSYLCERAMIDE
  • DOI:
    10.1016/s0021-9258(18)96226-5
  • 发表时间:
    1967-03-10
  • 期刊:
  • 影响因子:
  • 作者:
    Roscoe O. Brady;Andrew E. Gal;Roy M. Bradley;Erik Mårtensson
  • 通讯作者:
    Erik Mårtensson
The Metabolism of Glucocerebrosides: III. PURIFICATION AND PROPERTIES OF A GLUCOSYL- AND GALACTOSYLCERAMIDE-CLEAVING ENZYME FROM RAT INTESTINAL TISSUE
  • DOI:
    10.1016/s0021-9258(18)97108-5
  • 发表时间:
    1965-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Roscoe O. Brady;Andrew E. Gal;Julian N. Kanfer;Roy M. Bradley
  • 通讯作者:
    Roy M. Bradley
ENZYMATIC THIOLTRANSACETYLATION
  • DOI:
    10.1016/s0021-9258(18)71152-6
  • 发表时间:
    1954-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Roscoe O. Brady;E.R. Stadtman
  • 通讯作者:
    E.R. Stadtman
Gaucher's disease: lack of antibody response in 12 patients following repeated intravenous infusions of mannose terminal glucocerebrosidase
  • DOI:
    10.1016/0022-1759(91)90400-a
  • 发表时间:
    1991-03-01
  • 期刊:
  • 影响因子:
  • 作者:
    Gary J. Murray;Karyn D. Howard;Susan M. Richards;Norman W. Barton;Roscoe O. Brady
  • 通讯作者:
    Roscoe O. Brady
SYNTHESIS OF RADIOACTIVE FATTY ACIDS IN VITRO AND ITS HORMONAL CONTROL
  • DOI:
    10.1016/s0021-9258(18)50901-7
  • 发表时间:
    1951-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Roscoe O. Brady;Francis D.W. Lukens;Samuel Gurin
  • 通讯作者:
    Samuel Gurin

Roscoe O. Brady的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Roscoe O. Brady', 18)}}的其他基金

Empirical validation of a cerebellar-cortical hallucination circuit
小脑皮质幻觉回路的实证验证
  • 批准号:
    10543553
  • 财政年份:
    2022
  • 资助金额:
    $ 66.44万
  • 项目类别:
Network Mediation of Experiential and Expressive Deficits in Psychotic Disorders
精神障碍体验和表达缺陷的网络中介
  • 批准号:
    10304926
  • 财政年份:
    2019
  • 资助金额:
    $ 66.44万
  • 项目类别:
Network Mediation of Experiential and Expressive Deficits in Psychotic Disorders
精神障碍体验和表达缺陷的网络中介
  • 批准号:
    10527321
  • 财政年份:
    2019
  • 资助金额:
    $ 66.44万
  • 项目类别:
Network Mediation of Experiential and Expressive Deficits in Psychotic Disorders
精神障碍体验和表达缺陷的网络中介
  • 批准号:
    10058274
  • 财政年份:
    2019
  • 资助金额:
    $ 66.44万
  • 项目类别:
Longitudinal Imaging Studies in Bipolar Disorder
双相情感障碍的纵向影像研究
  • 批准号:
    9188573
  • 财政年份:
    2013
  • 资助金额:
    $ 66.44万
  • 项目类别:
Longitudinal Imaging Studies in Bipolar Disorder
双相情感障碍的纵向影像研究
  • 批准号:
    8785136
  • 财政年份:
    2013
  • 资助金额:
    $ 66.44万
  • 项目类别:
Longitudinal Imaging Studies in Bipolar Disorder
双相情感障碍的纵向影像研究
  • 批准号:
    8635732
  • 财政年份:
    2013
  • 资助金额:
    $ 66.44万
  • 项目类别:
Longitudinal Imaging Studies in Bipolar Disorder
双相情感障碍的纵向影像研究
  • 批准号:
    8957410
  • 财政年份:
    2013
  • 资助金额:
    $ 66.44万
  • 项目类别:

相似海外基金

Empirical validation of a cerebellar-cortical hallucination circuit
小脑皮质幻觉回路的实证验证
  • 批准号:
    10543553
  • 财政年份:
    2022
  • 资助金额:
    $ 66.44万
  • 项目类别:
CSRD Research Career Scientist Award Application
CSRD研究职业科学家奖申请
  • 批准号:
    10657600
  • 财政年份:
    2022
  • 资助金额:
    $ 66.44万
  • 项目类别:
MR Brain Diffusion Tensor Imaging in Schizophrenia
精神分裂症的 MR 脑扩散张量成像
  • 批准号:
    8195956
  • 财政年份:
    2009
  • 资助金额:
    $ 66.44万
  • 项目类别:
MR Brain Diffusion Tensor Imaging in Schizophrenia
精神分裂症的 MR 脑扩散张量成像
  • 批准号:
    8586852
  • 财政年份:
    2009
  • 资助金额:
    $ 66.44万
  • 项目类别:
Pilot Trial of Bupropion versus Placebo for Methamphetamine Abuse in Adolescents
安非他酮与安慰剂治疗青少年甲基苯丙胺滥用的试点试验
  • 批准号:
    7642248
  • 财政年份:
    2009
  • 资助金额:
    $ 66.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了